Unknown

Dataset Information

0

Suppression of androgen receptor enhances the self-renewal of mesenchymal stem cells through elevated expression of EGFR.


ABSTRACT: Bone marrow derived mesenchymal stem cells (BM-MSCs) have been widely applied in several clinical trials of diseases, such as myocardial infarction, liver cirrhosis, neurodegenerative disease, and osteogenesis imperfecta. Although most studies demonstrated that transplantation of BM-MSCs did exert a temporary relief and short-term therapeutic effects, eventually all symptoms recur, therefore it is essential to improve the therapeutic efficacy of transplantation by either elevating the self-renewal of BM-MSCs or enhancing their survival rate. Herein we demonstrated that the BM-MSCs and adipocyte derived mesenchymal stem cells (ADSCs) isolated from the androgen receptor (AR) knockout mice have higher self-renewal ability than those obtained from the wild-type mice. Knockdown of AR in MSC cell lines exhibited similar results. Mechanistic dissection studies showed that the depletion of AR resulted in activation of Erk and Akt signaling pathways through epidermal growth factor receptor (EGFR) activation or pathway to mediate higher self-renewal of BM-MSCs. Targeting AR signals using ASC-J9® (an AR degradation enhancer), hydroxyflutamide (antagonist of AR), and AR-siRNA all led to enhanced self-renewal of MSCs, suggesting the future possibility of using these anti-AR agents in therapeutic approaches.

SUBMITTER: Huang CK 

PROVIDER: S-EPMC3673551 | biostudies-literature | 2013 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Suppression of androgen receptor enhances the self-renewal of mesenchymal stem cells through elevated expression of EGFR.

Huang Chiung-Kuei CK   Tsai Meng-Yin MY   Luo Jie J   Kang Hong-Yo HY   Lee Soo Ok SO   Chang Chawnshang C  

Biochimica et biophysica acta 20130117 5


Bone marrow derived mesenchymal stem cells (BM-MSCs) have been widely applied in several clinical trials of diseases, such as myocardial infarction, liver cirrhosis, neurodegenerative disease, and osteogenesis imperfecta. Although most studies demonstrated that transplantation of BM-MSCs did exert a temporary relief and short-term therapeutic effects, eventually all symptoms recur, therefore it is essential to improve the therapeutic efficacy of transplantation by either elevating the self-renew  ...[more]

Similar Datasets

| S-EPMC5845163 | biostudies-other
| S-EPMC5822422 | biostudies-literature
| S-EPMC10252885 | biostudies-literature
| S-EPMC6288384 | biostudies-literature
| S-EPMC4175555 | biostudies-literature
| S-EPMC5204355 | biostudies-literature
| S-EPMC2941915 | biostudies-literature
| S-EPMC10385979 | biostudies-literature
| S-EPMC6357870 | biostudies-literature
| S-EPMC2975189 | biostudies-literature